TY - JOUR
T1 - Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia
AU - Johansson, Patricia
AU - Bergmann, Anke
AU - Rahmann, Sven
AU - Wohlers, Inken
AU - Scholtysik, René
AU - Przekopowitz, Martina
AU - Seifert, Marc
AU - Tschurtschenthaler, Gertraud
AU - Webersinke, Gerald
AU - Jäger, Ulrich
AU - Siebert, Reiner
AU - Klein-Hitpass, Ludger
AU - Dührsen, Ulrich
AU - Dürig, Jan
AU - Küppers, Ralf
N1 - Publisher Copyright:
© 2015 UICC.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - The pathogenesis of T-cell large granular lymphocytic leukemia (T-LGL) is poorly understood, as STAT3 mutations are the only known frequent genetic lesions. Here, we identified non-synonymous alterations in the TNFAIP3 tumor suppressor gene in 3 of 39 T-LGL. In two cases these were somatic mutations, in one case the somatic origin was likely. A further case harbored a SNP that is a known risk allele for autoimmune diseases and B cell lymphomas. Thus, TNFAIP3 mutations represent recurrent genetic lesions in T-LGL that affect about 8% of cases, likely contributing to deregulated NF-κB activity in this leukemia. What's New? T-cell large granular lymphocytic leukemia (T-LGL) is often associated with mutations in the STAT3 gene, but associations with other genetic mutations remain unknown. Here the authors identified non-synonymous mutations in the gene encoding TNF-alpha-induced protein 3 (TNFAIP3), a negative regulator of NF-kappa B signaling, in three patients with T-LGL. The study underscores the important role of NF-kappa B activity in this otherwise poorly understood lymphoid malignancy.
AB - The pathogenesis of T-cell large granular lymphocytic leukemia (T-LGL) is poorly understood, as STAT3 mutations are the only known frequent genetic lesions. Here, we identified non-synonymous alterations in the TNFAIP3 tumor suppressor gene in 3 of 39 T-LGL. In two cases these were somatic mutations, in one case the somatic origin was likely. A further case harbored a SNP that is a known risk allele for autoimmune diseases and B cell lymphomas. Thus, TNFAIP3 mutations represent recurrent genetic lesions in T-LGL that affect about 8% of cases, likely contributing to deregulated NF-κB activity in this leukemia. What's New? T-cell large granular lymphocytic leukemia (T-LGL) is often associated with mutations in the STAT3 gene, but associations with other genetic mutations remain unknown. Here the authors identified non-synonymous mutations in the gene encoding TNF-alpha-induced protein 3 (TNFAIP3), a negative regulator of NF-kappa B signaling, in three patients with T-LGL. The study underscores the important role of NF-kappa B activity in this otherwise poorly understood lymphoid malignancy.
UR - http://www.scopus.com/inward/record.url?scp=84944197931&partnerID=8YFLogxK
U2 - 10.1002/ijc.29697
DO - 10.1002/ijc.29697
M3 - Journal articles
C2 - 26199174
AN - SCOPUS:84944197931
SN - 0020-7136
VL - 138
SP - 121
EP - 124
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 1
ER -